COVID-19: US Govt Gobbles Up 150 Million BinaxNOW Rapid Tests From Abbott
Executive Summary
Abbott will be paid $760m for the tests under a contract with the Department of Health and Human Services and the Department of Defense.
You may also be interested in...
US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
Philips Breathing Machines Recall: 21,000+ Adverse Events Reported To FDA In 1 Year
The tens of thousands of Medical Device Reports sent to the US agency included 124 reports of death associated with Philips’ June 2021 recall of millions of BiPAPs, CPAPs, and other mechanical ventilator devices.